Expanding Our Knowledge About Daratumumab and More

Three important new reports are shedding light on how daratumumab works, reports IMF Chairman Dr. Brian Durie in his blog this week. “Our understanding of its benefits—when used alone and in combinations—is evolving rapidly.” But is treatment outpacing reimbursement? Also, this week, Dr. Durie touches on cancer in 9/11 responders, a study that suggests social status may affect outcomes, and a new bestseller that explores the science-fiction-sounding “microbiome.”
Source: International Myeloma Foundation - Category: Hematology Source Type: news